Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
HER2突变型转移性乳腺癌中HER激酶抑制剂的疗效及反应决定因素
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-19-0966
Smyth, Lillian M; Piha-Paul, Sarina A; Won, Helen H; Schram, Alison M; Saura, Cristina; Loi, Sherene; Lu, Janice; Shapiro, Geoffrey I; Juric, Dejan; Mayer, Ingrid A; Arteaga, Carlos L; de la Fuente, Macarena I; Brufksy, Adam M; Spanggaard, Iben; Mau-Sørensen, Morten; Arnedos, Monica; Moreno, Victor; Boni, Valentina; Sohn, Joohyuk; Schwartzberg, Lee S; Gonzàlez-Farré, Xavier; Cervantes, Andrés; Bidard, François-Clement; Gorelick, Alexander N; Lanman, Richard B; Nagy, Rebecca J; Ulaner, Gary A; Chandarlapaty, Sarat; Jhaveri, Komal; Gavrila, Elena I; Zimel, Catherine; Selcuklu, S Duygu; Melcer, Myra; Samoila, Aliaksandra; Cai, Yanyan; Scaltriti, Maurizio; Mann, Grace; Xu, Feng; Eli, Lisa D; Dujka, Melanie; Lalani, Alshad S; Bryce, Richard; Baselga, José; Taylor, Barry S; Solit, David B; Meric-Bernstam, Funda; Hyman, David M